Intellia Therapeutics, Inc. (NTLA)
12.89
-0.60
(-4.45%)
USD |
NASDAQ |
Jun 09, 16:00
12.96
+0.07
(+0.54%)
After-Hours: 17:58
Intellia Therapeutics Shareholders Equity (Quarterly) : 620.94M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.164B |
| Twist Bioscience Corp. | 455.09M |
| Tenaya Therapeutics, Inc. | 106.19M |
| HCW Biologics Inc. | 5.762M |
| Arrowhead Pharmaceuticals, Inc. | 613.98M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 758.78M |
| Total Liabilities (Quarterly) | 137.84M |
| Debt to Equity Ratio | 0.1296 |
| Current Ratio | 6.102 |
| Net Debt Paydown Yield | 1.68% |